Best Medication Dosing Reference for Pediatric and Adolescent Populations
The Harriet Lane Handbook is the most widely recommended and practical medication dosing reference for children and adolescents in clinical practice.
Primary Recommended Resources
First-Tier References
Harriet Lane Handbook: This is consistently cited as a Category A resource (essential for basic pharmacy libraries) and provides comprehensive, practical dosing information for pediatric patients 1.
The Pediatric Drug Handbook: Another Category A resource that offers focused, accessible medication dosing guidance specifically designed for pediatric populations 1.
Nelson Textbook of Pediatrics: While more comprehensive and expensive (Category A), this serves as an authoritative reference that includes detailed pharmacotherapy sections 1.
Specialized Dosing Resources
Pocketbook of Pediatric Antimicrobial Therapy: Essential for infectious disease management, providing specific antibiotic dosing recommendations 1. This is particularly valuable given that pediatric antibiotic dosing requires careful attention to weight-based calculations and age-specific considerations 2, 3.
Manual of Pediatric Therapeutics: Offers broader therapeutic guidance beyond simple dosing tables 1.
Critical Dosing Principles to Remember
Weight-Based Calculations Are Not Simple Scaling
Children are not small adults: Simple weight-based scaling from adult doses is inappropriate and can lead to underdosing in children or overdosing in neonates 3.
Dosing must account for developmental pharmacokinetics and pharmacodynamics that vary significantly across pediatric age groups 3.
Age-Specific Considerations
Neonatal dosing requires special attention, with different recommendations based on postmenstrual age and weight (e.g., <1200g, <2000g, >2000g) 3, 4.
Adolescents may require adult-equivalent dosing for some medications but pediatric approaches for others, depending on skeletal maturity and specific drug characteristics 2.
Supplementary Resources by Clinical Context
For Intensive Care Settings
- Textbook of Pediatric Intensive Care: Provides dosing for critically ill children where standard recommendations may need modification 1.
For Emergency/Acute Behavioral Management
- Specific dosing tables exist for chemical restraint medications, with clear age-based (child 6-12 years vs. adolescent ≥13 years) and weight-based recommendations 2.
For Infectious Diseases
Report of the Committee on Infectious Diseases (Red Book): Authoritative guidance from the American Academy of Pediatrics 1.
Specific guidelines exist for community-acquired pneumonia with detailed dosing tables stratified by pathogen and route of administration 2.
Common Pitfalls to Avoid
Renal Adjustment Oversights
Always adjust doses for renally eliminated drugs (aminoglycosides, beta-lactams) in patients with renal impairment 3.
Creatinine clearance-based adjustments are essential for medications like oseltamivir (<30 mL/min requires dose reduction) 2.
Neonatal-Specific Contraindications
Never use ceftriaxone in hyperbilirubinemic neonates due to bilirubin displacement and kernicterus risk 3.
Pemoline should not be used despite effectiveness due to hepatic failure risk 2.
Maximum Dose Confusion
Pediatric doses should not exceed adult maximum doses even when weight-based calculations suggest higher amounts 2.
For example, stimulant medications have specific maximum daily doses (60 mg MPH, 40 mg amphetamines per PDR) that should rarely be exceeded 2.
Electronic Prescribing Considerations
Modern e-prescribing systems should incorporate automated dose-rounding recommendations that account for medication-specific tolerances 2.
Three categories guide rounding philosophy: (1) medications requiring judicious rounding to retain intended effect, (2) medications rounded with attention to unintended effects, and (3) medications rarely rounded due to toxicity potential 2.
Practical Implementation
For Outpatient Settings
The Harriet Lane Handbook provides the most practical, portable reference for office-based prescribing 1.
Supplement with specific disease-focused guidelines (e.g., IDSA, AAP) for complex conditions 2, 3.